Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody

(Synonyms: NPD, ASMASE, ASM) Copy Product Info
🥰Excellent

Synonyms: NPD, ASMASE, ASM

Catalog No. TMAB-00037 Copy Product Info
🥰Excellent
Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody is a Rabbit antibody targeting Acid sphingomyelinase/SMPD1. Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody can be used in FCM, IF, IHC-Fr, IHC-P, WB.
Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody
Pack SizePriceUSA StockGlobal StockQuantity
50 μL$2217-10 days7-10 days
100 μL$3737-10 days7-10 days
200 μL$5277-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:/
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody is a Rabbit antibody targeting Acid sphingomyelinase/SMPD1. Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody can be used in FCM, IF, IHC-Fr, IHC-P, WB.
SynonymsNPD, ASMASE, ASM
Ig Type
IgG
Reactivity
Human,Rat (predicted:Mouse,Dog,Pig,Cow,Rabbit)
Application
Recommended Dose
WB: 1:500-2000; IHC-P: 1:100-500; IHC-Fr: 1:100-500; IF: 1:100-500; FCM: 2ug/Test
Antibody Type
Polyclonal
Host SpeciesRabbit
Subcellular LocalizationLysosome.
ConstructionPolyclonal Antibody
PurificationProtein A purified
AppearanceLiquid
Formulation0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Concentration1 mg/mL
Research BackgroundConverts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. Isoform 2 and isoform 3 have lost catalytic activity. Involvement in disease: Defects in SMPD1 are the cause of Niemann-Pick disease type A (NPDA) ; also known as Niemann-Pick disease classical infantile form. It is an early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.
Antigen Details
Immunogen
KLH conjugated synthetic peptide: human Acid sphingomyelinase
Antigen Species
Human
Gene Name
SMPD1
Gene ID
Protein Name
Sphingomyelin phosphodiesterase
Uniprot ID
Biology Area
Associated Proteins,Neurodegenerative disease,Lipid metabolism
Function
Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. Isoform 2 and isoform 3 have lost catalytic activity.
Chemical Properties
Molecular WeightTheoretical: 64 kDa. Actual: 69 kDa.
Stability & Storage
Stability & StorageStore at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: Anti-Acid sphingomyelinase/SMPD1 Polyclonal Antibody molecular weight